Sign in

Private company

Theratechnologies Inc.

Theratechnologies Inc. is a Canadian pharmaceutical preparations company based in Montreal.2

Last updated Oct 21, 2026.

Overview

$85.9MRevenue, fiscal 20243
-$8.3MNet income, fiscal 20243
  • IndustryPharmaceutical Preparations2
  • HeadquartersMontreal, Canada2
  • Incorporated inQuebec, Canada4
  • Business address2015 Peel Street, 11Th Floor, Montreal4
  • Filer categoryNon-accelerated filer, Emerging growth company4
  • Legal formSociété par actions par Loi sur les sociétés par actions2
  • LEI5493003Q78Q8VKGF14592
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered address500-2015 rue Peel, H3A 1T8 Montreal, Canada2
  • Registered withEnterprise Register, 11422370162

See how the biggest companies compare on our leaderboards

Our legal name and commercial name is Theratechnologies Inc. Our head office and principal place of business is located at 2015 Peel Street, 11 th Floor, Montreal, Québec, Canada H3A 1T8. Our telephone number is (514) 336-7800. Our website is www.theratech.com. Our agent for service in the United States is CT Corporation System, 28 Liberty Street, New York, NY 10005 (212) 894-8940.5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

9.5%Operating margin3
-9.7%Net margin3
5.0%Revenue growth, 20243
$2.4MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue24¢$20.4M
  • Other costs74¢$63.4M
  • Income tax2¢$2.0M

Out of $85.9M in revenue.3 The company lost money this year.

Where each dollar of operating cash went, fiscal 2024

  • Kept or used elsewhere100¢$2.4M

Out of $2.4M of cash from operations.3

Financial statements

Revenue67893$85.9M in 2024+90% since 2018
0$25.0M$50.0M$75.0M$100.0M2018: $45.2M$45.2M20182019: $63.2M$63.2M2019+40%2020: $66.1M$66.1M2020+4%2021: $69.8M$69.8M2021+6%2022: $80.1M$80.1M2022+15%2023: $81.8M$81.8M2023+2%2024: $85.9M$85.9M2024+5%
Operating income67893$8.2M in 2024
-$40.0M-$20.0M0$20.0M2018: -$3.6M-$3.6M20182019: -$8.5M-$8.5M2019+139%2020: -$18.0M-$18.0M2020+111%2021: -$25.2M-$25.2M2021+41%2022: -$39.9M-$39.9M2022+58%2023: -$10.6M-$10.6M2023−73%2024: $8.2M$8.2M2024
Net income67893-$8.3M in 2024+77% since 2018
-$60.0M-$40.0M-$20.0M02018: -$4.7M-$4.7M20182019: -$12.5M-$12.5M2019+166%2020: -$22.7M-$22.7M2020+81%2021: -$31.7M-$31.7M2021+40%2022: -$47.2M-$47.2M2022+49%2023: -$24.0M-$24.0M2023−49%2024: -$8.3M-$8.3M2024−65%
Fiscal year20172018201920202021202220232024
Revenue$45.2M6$63.2M7$66.1M8$69.8M9$80.1M3$81.8M3$85.9M3
Cost of revenue$18.4M9$23.8M3$19.6M3$20.4M3
Operating income-$3.6M6-$8.5M7-$18.0M8-$25.2M9-$39.9M3-$10.6M3$8.2M3
Income before tax-$31.7M9-$46.8M3-$23.5M3-$6.3M3
Income tax$63.0K9$443.0K3$421.0K3$2.0M3
Net income-$4.7M6-$12.5M7-$22.7M8-$31.7M9-$47.2M3-$24.0M3-$8.3M3
Earnings per share-$137.009-$1.983-$0.913-$0.173
Earnings per share (diluted)-$137.009-$1.983-$0.913-$0.173
Shares (weighted, basic)19.3M shares923.8M shares324.2M shares346.0M shares3
Shares (weighted, diluted)23.1M shares923.8M shares326.3M shares349.4M shares3

Compare Theratechnologies Inc. with another company

Corporate structure

Theratechnologies Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Theratechnologies Inc.

  • Theratechnologies Inc. Montreal, Quebec, Canada

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Theratechnologies Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$222.0K3 Nov 30, 2024$1.2M3 Nov 30, 2023−81.6%
Operating-lease assets (leased space)$1.0M3 Nov 30, 2024$770.0K3 Nov 30, 2023+34.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$15.9M3 Nov 30, 2024$34.1M3 Nov 30, 2023−53.4%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$7.6M3 Nov 30, 2024$12.5M3 Nov 30, 2023−39.4%

Filings

155 filings to the SEC since October 2021: 4 annual reports, 19 large holders, 132 other. The latest 20:

  1. Nov 28, 2025EFFECT EDGAR
  2. Nov 26, 202515-12G EDGAR
  3. Nov 26, 2025POS AM EDGAR
  4. Nov 14, 2025SCHEDULE 13G/A EDGAR
  5. Sep 29, 2025SCHEDULE 13G EDGAR
  6. Sep 25, 20256-K EDGAR
  7. Sep 17, 20256-K EDGAR
  8. Sep 12, 20256-K EDGAR
  9. Sep 12, 20256-K EDGAR
  10. Sep 5, 20256-K EDGAR
  11. Sep 2, 20256-K EDGAR
  12. Aug 18, 20256-K EDGAR
  13. Aug 18, 20256-K EDGAR
  14. Aug 5, 2025SCHEDULE 13G/A EDGAR
  15. Jul 29, 2025SCHEDULE 13G/A EDGAR
  16. Jul 18, 20256-K EDGAR
  17. Jul 10, 20256-K EDGAR
  18. Jul 9, 20256-K EDGAR
  19. Jul 9, 20256-K EDGAR
  20. Jul 9, 20256-K EDGAR

The 155 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Theratechnologies Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARTheratechnologies Inc.1
  • CIK0001512717
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company5
  • Incorporated inQuebec5
  • Fiscal year endsNovember 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address2015 Peel Street, 11Th Floor, Montreal, Quebec, Canada1
  • Phone1 438-858-39671
  • Shares outstanding45,980,019 shares as of Nov 30, 20245
  • AuditorKPMG LLP, Montreal, Quebec, Canada PCAOB ID 85; no auditor attestation of internal control over financial reporting5
  • On EDGAR sinceFeb 22, 20111
  • Filings284 in all: 6-K (191), SC 13G/A (18), SC 13G (8), 40-F (6), CORRESP (6), F-X (6), SCHEDULE 13G/A (6), UPLOAD (5)1
    All 31 form types

    20-F (4), SUPPL (4), EFFECT (3), F-10 (3), 40-F/A (2), 40FR12B (2), CT ORDER (2), F-10/A (2), SC 13D (2), 15-12B (1), 15-12G (1), 20-F/A (1), 25 (1), 25-NSE (1), 6-K/A (1), CERT (1), CERTNAS (1), F-3 (1), F-3/A (1), POS AM (1), RW (1), SCHEDULE 13D/A (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (20-F) Feb 26, 2025

Securities registered for trading

ClassSymbolExchange
Common Shares, no par valueTHTXNASDAQ

From the cover page of the 20-F filed Feb 26, 2025 (Section 12(b) of the Exchange Act).5

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17